The design of biocatalytic processes for industrial synthetic chemistry is determined in large part by the choice of isolated enzyme or whole-cell catalyst form. In the present paper, the considerations for choice are identified and some important classes of bioconversion are discussed in relation to the choice to be made. Recent developments in cell and protein engineering as well as reactor and process engineering are discussed in addition.
No takes yet. Share an insight, caveat, or question.
John M. Woodley (2006) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context:
More from Biochemical Society Transactions